Skip to Main Content

Paper Details

Association of Genomic Domains in <i>BRCA1</i> and <i>BRCA2</i> with Prostate Cancer Risk and Aggressiveness.
Cancer Res
33
2020
3' region, BRCA1, BRCA1/2, BRCA2, BRCA2 PSVs, BRCA2 mutation, Genomic Domains, PSVs, Prostate Cancer, c.756-c.1000, prostate cancer
Author NameAffiliation
Irene L AndrulisFred A. Litwin Center for Cancer Genetics, Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital
Irene L AndrulisUniversity of Toronto
Irene L AndrulisFred A. Litwin Center for Cancer Genetics, Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital
Irene L AndrulisUniversity of Toronto
Javier Ben??tezSpanish National Cancer Research Centre (CNIO)
Javier Ben??tez
Ian G CampbellPeter MacCallum Cancer Center
Ian G CampbellThe University of Melbourne
Wendy K ChungColumbia University
Wendy K ChungColumbia University
Fergus J CouchMayo Clinic
Fergus J CouchMayo Clinic
Susan M DomchekAbramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania
Douglas F EastonUniversity of Cambridge
Douglas F EastonUniversity of Cambridge
Michael R StrattonUniversity of Southampton
Douglas F EastonThe Institute of Cancer Research and Royal Marsden NHS Foundation Trust
Peter J HulickCenter for Medical Genetics, NorthShore University HealthSystem
Peter J HulickThe University of Chicago Pritzker School of Medicine
Peter J HulickCenter for Medical Genetics, NorthShore University HealthSystem
Peter J HulickThe University of Chicago Pritzker School of Medicine
Louise IzattClinical Genetics, Guy's and St Thomas' NHS Foundation Trust
Esther M JohnStanford Cancer Institute, Stanford University School of Medicine
Jeong-Won LeeUlsan University College of Medicine and Asan Medical Center
Siranoush ManoukianFondazione IRCCS (Istituto di Ricovero e Cura a Carattere Scientifico), Istituto Nazionale dei Tumori di Milano
Katherine L NathansonAbramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania
Ana OsorioSpanish National Cancer Research Centre (CNIO)
Ana Osorio
Claus-Eric OttInstitute for Medical Genetics and Human Genetics, Charite - Universitatsmedizin Berlin, corporate member of Freie Universitat Berlin, Humboldt-Universitat zu Berlin, and Berlin Institute of Health
Domenico PalliInstitute for Cancer Research, Prevention and Clinical Network (ISPRO)
Paolo Radicein Fondazione IRCCS (Istituto Di Ricovero e Cura a Carattere Scientifico) Istituto Nazionale dei Tumori (INT)
Kathryn J RuddyMayo Clinic
Caroline SeynaeveFamily Cancer Clinic, Erasmus MC Cancer Institute
Georgia Chenevix-TrenchQIMR Berghofer Medical Research Institute
Georgia Chenevix-TrenchQIMR Berghofer Medical Research Institute
Doris SteinemannInstitute of Cell and Molecular Pathology, Hannover Medical School
Christi J van AsperenLeiden University Medical Center
Anthony V D'AmicoDana-Farber Cancer Institute and Brigham and Women's Hospital
Matthew L FreedmanDana-Farber Cancer Institute. Boston
Matthew L FreedmanDana-Farber Cancer Institute. Boston
Mark M PomerantzDana-Farber Cancer Institute. Boston
Mark M PomerantzDana-Farber Cancer Institute. Boston
Georgia Chenevix-TrenchQIMR Berghofer Medical Research Institute
Georgia Chenevix-TrenchQIMR Berghofer Medical Research Institute
Timothy R RebbeckHarvard T.H. Chan School of Public Health
Timothy R RebbeckDana-Farber Cancer Institute. Boston
  • 1 - 46

Datasets